Terms and conditions of use

NovoCare® Pharmacy (CoAssist Pharmacy d/b/a NovoCare® Pharmacy)

Covered products:

Wegovy® (semaglutide) injection 2.4 mg

Total strength per total volume
NDC

0.25 mg/0.5 mL
0169-4525-14


0.5 mg/0.5 mL
0169-4505-14


1 mg/0.5 mL
0169-4501-14 


1.7 mg/0.75 mL
0169-4517-14


2.4 mg/0.75 mL
0169-4524-14

Wegovy® (semaglutide) tablets 25 mg

Total strength per tablet
NDC

1.5 mg
00169-4415-31


4 mg
00169-4404-31


9 mg
00169-4409-31


25 mg
00169-4425-31

Wegovy® HD (semaglutide) injection 7.2mg 

Total strength per tablet
NDC

7.2 mg/0.5 mL
0169-4572-14

Eligibility and Restrictions

In order to participate in this Wegovy® NovoCare® Pharmacy cash/self-pay program, patient must have a valid prescription for Wegovy®. A valid Prescriber ID# is required on the prescription. 

Patients may only participate in this cash/self-pay program if they have been prescribed Wegovy® for an FDA-approved indication within Wegovy®’s labeling.

Patients may participate in this program if they self-pay. If the patient has insurance and fulfills their prescription through this program, the transaction will process outside of any insurance. Patient payments will not count toward any deductibles and cannot be applied to a patient’s maximum out-of-pocket costs. 

By using this program, patients certify that he/she meets the eligibility criteria, will comply with the terms and conditions described herein, and will not seek reimbursement or otherwise submit a claim to an insurer for any medication received through this program.

Patients participating in Medicare Part D or a Medicare Advantage prescription drug plan must agree to the following conditions:

  • The patient must agree not to seek reimbursement from their Medicare Part D or Medicare Advantage prescription plan for their out-of-pocket costs for their Wegovy® prescription or count the costs of their prescription toward their deductible or True out-of-pocket (“TrOOP”) costs
  • The patient must also agree to purchase all of their Wegovy® prescriptions through the program for the entire calendar year
  • The patient must agree to permit Novo Nordisk to notify the patient’s Medicare Part D or Medicare Advantage prescription plan about their participation in the program

Novo Nordisk’s Eligibility and Restrictions, and Program Details, may change from time to time, and for the most recent version, please visit this webpage. Reconfirmation of patient information may be requested periodically to ensure accuracy of data and compliance with terms. Patients with questions about the program may call 1‑888‑809‑3942.

This offer is not insurance. This offer is not contingent on any past, current, or future purchase of Wegovy®. This offer cannot be combined with any other coupon, free trial, discount, prescription savings card, or other offer not associated with this offer. This offer is valid only in the United States and its territories, unless prohibited by law.

Program Details

NovoCare® Pharmacy operates through licensed pharmacies that dispense product under a cash/self-pay model and insurance is not accepted. These cash/self-pay prescriptions are filled by CenterWell® Pharmacy or CoAssist Pharmacy d/b/a NovoCare® Pharmacy.

When a prescription is received from a licensed prescriber, NovoCare® will review and validate the prescription. Patients with insurance coverage for Wegovy® will have the option to utilize the cash program through CenterWell® Pharmacy and/or CoAssist Pharmacy d/b/a NovoCare® Pharmacy (“NovoCare® Pharmacy”) or transfer the prescription to a retail pharmacy if they choose to apply their prescription insurance to the prescription fulfillment.

The tables below explain what patients enrolled in the program can pay based on which medicine they receive:

Wegovy® (semaglutide) injection 2.4 mg, 7.2 mg:

Wegovy® Injectable Self-pay offer details

NDC

Description

Limited Time Offera patient price

The Limited Time Offer patient price is available to new patients (as defined below) who meet the Limited Time Offer requirements. This offer applies to a maximum of the first two (2) 28‑day fills during the applicable offer period. Any third fill will be priced at the Standard Offerb patient price.

1-monthc

2-monthc

3-monthc


00169-4525-14

Wegovy® - 0.25 mg 4 Single-Dose Prefilled Pens

$199.00

NA

NA


00169-4505-14

Wegovy® - 0.5 mg 4 Single-Dose Prefilled Pens

$199.00

NA

NA


Wegovy® Injectable


NDC

Description

Standard Offerb patient price

1-monthc

2-monthc

3-monthc


00169-4525-14

Wegovy® - 0.25 mg 4 Single-Dose Prefilled Pens

$349.00

$698.00

$1,047.00


00169-4505-14

Wegovy® - 0.5 mg 4 Single-Dose Prefilled Pens

$349.00

$698.00

$1,047.00


00169-4501-14

Wegovy® - 1.0 mg 4 Single-Dose Prefilled Pens

$349.00

$698.00

$1,047.00


00169-4517-14

Wegovy® - 1.7 mg 4 Single-Dose Prefilled Pens

$349.00

$698.00

$1,047.00


00169-4524-14

Wegovy® - 2.4 mg 4 Single-Dose Prefilled Pens

$349.00

$698.00

$1,047.00


00169-4572-14

Wegovy® HD - 7.2 mg 4 Single-Dose Prefilled Pens

$399.00

$798.00

$1,197.00

Limited Time Offera patient price
The Limited Time Offer patient price is available to new patients (as defined below) who meet the Limited Time Offer requirements. This offer applies to a maximum of the first two (2) 28‑day fills during the applicable offer period. Any third fill will be priced at the Standard Offerb patient price.


NDC
00169-4525-14

Description
Wegovy® - 0.25 mg 4 Single-Dose Prefilled Pens

1-monthc 2-monthsc 3-monthsc
$199.00 NA NA

NDC
00169-4505-14

Description
Wegovy® - 0.5 mg 4 Single-Dose Prefilled Pens

1-monthc 2-monthsc 3-monthsc
$199.00 NA NA

Wegovy® Injectable 
Standard Offerb Patient Price


NDC
00169-4525-14

Description
Wegovy® - 0.25 mg 4 Single-Dose Prefilled Pens

1-monthc 2-monthsc 3-monthsc
$349.00 $698.00 $1,047.00

NDC
00169-4505-14

Description
Wegovy® - 0.5 mg 4 Single-Dose Prefilled Pens

1-monthc 2-monthsc 3-monthsc
$349.00 $698.00 $1,047.00

NDC
00169-4501-14

Description
Wegovy® - 1.0 mg 4 Single-Dose Prefilled Pens

1-monthc 2-monthsc 3-monthsc
$349.00 $698.00 $1,047.00

NDC
00169-4517-14

Description
Wegovy® - 1.7 mg 4 Single-Dose Prefilled Pens

1-monthc 2-monthsc 3-monthsc
$349.00 $698.00 $1,047.00

NDC
00169-4524-14

Description
Wegovy® - 2.4 mg 4 Single-Dose Prefilled Pens

1-monthf 2-monthsf 3-monthsf
$349.00 $698.00 $1,047.00

NDC
00169-4572-14

Description
Wegovy® HD - 7.2 mg 4 Single-Dose Prefilled Pens

1-monthf 2-monthsf 3-monthsf
$399.00 $798.00 $1,197.00

aLimited Time Offer Requirements:

  • New Patients are eligible patients who have never filled a Wegovy® Injection prescription through NovoCare® Pharmacy.

  • For Wegovy® Injection- Eligible patients may use this Limited Time Offer if the prescription is written on or before 6/30/26, received by the pharmacy by the end of day on 6/30/26, and shipped on or before 7/30/26. The Limited Time Offer applies to the first two (2) 28‑day fills. The third fill will be priced at the Standard Offerb price

bStandard Offer:

  • Standard offer pricing applies to patients who are not eligible for the Limited Time Offer.

cFor Wegovy® Injection, a “1-Month” fill  shall refer to 1 box of 4 Single-Dose Prefilled Pens equivalent to a 28-Day Supply, “2-Month” fill shall refer to 2 boxes of 4 Single-Dose Prefilled Pens equivalent to a 56-Day Supply, and a “3-Month” fill shall refer to 3 boxes of 4 Single-Dose Prefilled Pens equivalent to a 84-Day Supply.

Wegovy® (semaglutide) tablets 25 mg:

Wegovy® Tablets Self-pay offer details

NDC

Description

Limited Time Offerd patient price

1-monthe

2-monthe

3-monthe


00169-4404-31

Wegovy® 4 mg 30 tablets Bottle

$149.00

NA

NA


NDC

Description

Standard Offerf patient price

1-monthe

2-monthe

3-monthe


00169-4415-31

Wegovy® 1.5 mg 30 tablets Bottle

$149.00

$298.00

$447.00


00169-4404-31

Wegovy® 4 mg 30 tablets Bottle

$199.00

$398.00

$597.00


00169-4409-31

Wegovy® 9 mg 30 tablets Bottle

$299.00

$598.00

$897.00


00169-4425-31

Wegovy® 25 mg 30 tablets Bottle

$299.00

$598.00

$897.00

Limited Time Offerd patient price


NDC
00169-4404-31

Description
Wegovy® 4 mg 30 tablets Bottle

1-monthe 2-monthse 3-monthse
$149.00 NA NA

Standard Offerf Patient Price


NDC
00169-4415-31

Description
Wegovy® 1.5 mg 30 tablets Bottle

1-monthe 2-monthse 3-monthse
$149.00 $298.00 $447.00

NDC
00169-4404-31

Description
Wegovy® 4 mg 30 tablets Bottle

1-monthe 2-monthse 3-monthse
$199.00 $398.00 $597.00

NDC
00169-4409-31

Description
Wegovy® 9 mg 30 tablets Bottle

1-monthe 2-monthse 3-monthse
$299.00 $598.00 $897.00

NDC
00169-4425-31

Description
Wegovy® 25 mg 30 tablets Bottle

1-monthe 2-monthse 3-monthse
$299.00 $598.00 $897.00

dLimited Time Offer Requirements:

  • New Patients are eligible patients who have never filled a Wegovy® Injection prescription through NovoCare® Pharmacy.

  • For Wegovy® tablets, eligible patients may use this Limited Time Offer if the prescription is written on or before 8/31/26, received by the pharmacy by the end of day on 8/31/26, and shipped on or before 9/30/26.

eFor Wegovy® tablets, a “1-Month” fill shall refer to 1 bottle of 30 tablets equivalent to a 30-Day Supply, a “2-Month” fill shall refer to 2 bottles of 30 tablets equivalent to a 60-Day Supply, and a “3-Month” fill shall refer to 3 bottles of 30 tablets equivalent to a 90-Day Supply. For the sake of clarity, Pharmacy will only dispense increments of 30 tablets.

fStandard Offer:

  • Standard offer pricing applies to patients who are not eligible for the Limited Time Offer.

Assurance of Medication Supply

This program will continue to enroll patients so long as each enrolled patient can receive a consistent supply of medication. This assurance is only applicable for those patients who remain enrolled and adherent to the treatment. Novo Nordisk reserves the right to pause or terminate enrollment to prioritize supply for those qualified.

Disclosure of Third-Party Partnerships

AssistRx: A patient solutions provider responsible for NovoCare®’s access and reimbursement live support program. They manage patient intake, outreach, and offer live support.

CoAssist: A licensed pharmacy in all 50 US states and territories that, for purposes of this program, is CoAssist Pharmacy d/b/a NovoCare® Pharmacy. CoAssist takes in the prescription after NovoCare®’s access and reimbursement live support program reviews the patient’s insurance type and benefits investigation to determine eligibility for program. Eligible patients may then have their HCP’s prescription transferred from CoAssist to CenterWell® Pharmacy, where CenterWell® further validates the prescription, and processes it for shipment to patient’s home, or CoAssist Pharmacy d/b/a NovoCare® Pharmacy may act as the dispensing pharmacy. 

CenterWell®: NovoCare®’s dispensing pharmacy responsible for patient accounts, payment collection, medication fulfillment, tracking, and shipping.